TITLE

Prison protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline?

AUTHOR(S)
CASADEI, V. M.; FERRI, C.; CALABRESE, E.; GRIMALDI, L. M. E.; FRANCESCHI, M.; VEGLIA, F.; LICASTRO, F.; MARIANI, C.
PUB. DATE
August 2001
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Aug2001, p279
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66345668

 

Related Articles

  • A century of cognitive decline? Yankner, Bruce A. // Nature;3/9/2000, Vol. 404 Issue 6774, p125 

    Discusses cognitive decline and its relation to Alzheimer's disease and ageing. Link between longevity and cognitive decline; Amyloid deposition in Alzheimer's disease; Mild cognitive impairment in the elderly; Abnormal accumulation of aggregated proteins in frontotemporal dementia.

  • The 129 codon polymorphism of the Prion Protein gene influences earlier cognitive performance in Down syndrome subjects. Del Bo, Roberto; Comi, Giacomo Pietro; Giorda, Roberto; Crimi, Marco; Locatelli, Federica; Martinelli-Boneschi, Filippo; Pozzoli, Uberto; Castelli, Enrico; Bresolin, Nereo; Scarlato, Guglielmo // Journal of Neurology;Jun2003, Vol. 250 Issue 6, p688 

    Recently, a frequent prion protein gene (PRNP) polymorphism consisting of a methionine (M) for valine (V) substitution at codon 129 has been associated with cognitive impairment in elderly individuals. Down syndrome (DS) is associated with mental retardation and development of Alzheimer-like...

  • Genes associated with Alzheimer Disease. Munshi, Anjana; Ahuja, Y. R. // Neurology Asia;Dec2010, Vol. 15 Issue 2, p109 

    Alzheimer's disease (AD) is one of the neurodegenerative disorders, characterized by gradual loss of memory, decline in other cognitive functions and decrease in functional capacity. Increasing age and a positive family history of dementia are the definite risk factors of the disease. Molecular...

  • STRESS AND ALZHEIMER'S SOME SURPRISING LINKS. Rosch, Paul J. // Health & Stress;Jan2011, Issue 1, p1 

    The article offers information on Alzheimer's disease. It discusses how one can determine if one has or will develop Alzheimer's and whether stress is a contributing factor to the disease. It talks about Minimal Cognitive Interference and whether or not it can be used to accurately diagnose...

  • Obezitede BiliÅŸsel Fonksiyon BozukluÄŸu ve Beslenme Ä°liÅŸkisi: Güncel Bakış. Macit, Sedanur; Karadağ, Makbule Gezmen // Journal of Marmara University Institute of Health Sciences;2014, Vol. 4 Issue 4, p241 

    Relationship between cognitive functioning impairment and nutrition in obesity: Current Perspective Obesity is one of the serious public health problems and its prevalence has been increasing in recent years. As well as causing health problems, obesity is associated with cognitive function...

  • Common genetic variation of the APOE gene and personality. Montag, Christian; Kunz, Lukas; Axmacher, Nikolai; Sariyska, Rayna; Lachmann, Bernd; Reuter, Martin // BMC Neuroscience;2014, Vol. 15 Issue 1, p1 

    Background A recent study yielded first evidence that personality plays an important role in explaining the influence of a prominent APOE polymorphism on cognitive decline and Alzheimer's disease (AD) in elderly humans. Adding to this, two earlier studies examined this polymorphism in the...

  • Same Variant Protects Against Alzheimer's, Cognitive Decline. Breindl, Anette // BioWorld Today;7/12/2012, Vol. 23 Issue 134, p1 

    The article discusses a study, which has identified a gene variant that is protective against both late-onset Alzheimer's disease and age-related cognitive decline. The study was conducted by Kari Stefansson, chief executive officer of deCode Genetics Inc. and colleagues. According to...

  • A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Jönsson, Erik G. // Nature;Jul2012, Vol. 488 Issue 7409, p96 

    The prevalence of dementia in the Western world in people over the age of 60 has been estimated to be greater than 5%, about two-thirds of which are due to Alzheimer's disease. The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence...

  • Does a single mutation cause Alzheimer's disease? Gill, Michael // BMJ: British Medical Journal (International Edition);2/16/91, Vol. 302 Issue 6773, p610 

    Focuses on the effects of DNA base mutation in the amyloid precursor protein gene on the development of Alzheimer's disease. Development of Alzheimer's disease in patients with Down's syndrome; Localization of familial autosomal gene in chromosome 21; Separation of polymorphic DNA markers from...

  • New Hope for Alzheimer's Treatment.  // Focus on Healthy Aging;Oct2012, Vol. 15 Issue 10, p1 

    The article offers information on the positive results of intravenous immunoglobulin (IVIG) revealed in the treatment of Alzheimer's disease (AD). It states that trials of IVIG had some success in treating cognitive decline in people with AD. It mentions that AD's traits include building-up of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics